Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Virtus Investment Partners
VRTS
$1.14B
| $2.83M | ﹤0.01% |
15,582
+2,665
| +21% | +$443K |
|
2552
Digital Turbine
APPS
$1.53B
| $2.82M | ﹤0.01% |
478,485
+4,551
| +1% | +$18.7K |
|
2553
Spectrum Brands
SPB
$2.09B
| $2.82M | ﹤0.01% |
53,260
+36,101
| +210% | +$2.15M |
|
2554
CALL
Hasbro
HAS
$13.6B
| $2.82M | ﹤0.01% |
38,200
-39,700
| -51% | -$2.5M |
|
2555
Trevi Therapeutics
TRVI
$2.59B
| $2.82M | ﹤0.01% |
515,476
+377,544
| +274% | +$2.35M |
|
2556
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.61B
| $2.82M | ﹤0.01% |
215,900
+192,900
| +839% | +$2.49M |
|
2557
Colliers International
CIGI
$5.41B
| $2.81M | ﹤0.01% |
21,561
+5,036
| +30% | +$613K |
|
|
PPTA
2558
Perpetua Resources
PPTA
$3.1B
| $2.81M | ﹤0.01% |
231,648
-941
| -0.4% | -$12.7K |
|
2559
Sprott Physical Silver Trust
PSLV
$13.3B
| $2.81M | ﹤0.01% |
229,639
+180,483
| +367% | +$2.04M |
|
2560
Flywire
FLYW
$2.22B
| $2.81M | ﹤0.01% |
240,221
-49,128
| -17% | -$500K |
|
2561
Viper Energy
VNOM
$14.8B
| $2.8M | ﹤0.01% |
73,385
+11,758
| +19% | +$476K |
|
2562
NextDecade
NEXT
$1.8B
| $2.8M | ﹤0.01% |
313,865
-273,423
| -47% | -$2.12M |
|
|
JBGS
2563
JBG SMITH
JBGS
$692M
| $2.79M | ﹤0.01% |
161,258
+54,749
| +51% | +$891K |
|
2564
Innoviva
INVA
$1.5B
| $2.79M | ﹤0.01% |
138,681
+55,333
| +66% | +$1.06M |
|
2565
Preferred Bank
PFBC
$1.28B
| $2.78M | ﹤0.01% |
32,114
+11,706
| +57% | +$965K |
|
2566
MP Materials
MP
$9.91B
| $2.78M | ﹤0.01% |
83,515
-78,530
| -48% | -$2M |
|
2567
FTI Consulting
FCN
$4.24B
| $2.78M | ﹤0.01% |
17,186
-8,061
| -32% | -$1.32M |
|
2568
CALL
Lyft
LYFT
$6.48B
| $2.77M | ﹤0.01% |
+175,900
| New | +$2.46M |
|
2569
Avnet
AVT
$7.87B
| $2.76M | ﹤0.01% |
52,075
-49,417
| -49% | -$2.45M |
|
2570
Sotera Health
SHC
$5.43B
| $2.76M | ﹤0.01% |
248,308
+148,431
| +149% | +$1.74M |
|
2571
United Parks & Resorts
PRKS
$2.04B
| $2.75M | ﹤0.01% |
58,414
+12,125
| +26% | +$541K |
|
|
JBIO
2572
Jade Biosciences
JBIO
$1.51B
| $2.75M | ﹤0.01% |
274,830
+274,413
| +65,806% | +$9.34M |
|
2573
CALL
Ares Capital
ARCC
$14.5B
| $2.75M | ﹤0.01% |
+125,000
| New | +$2.66M |
|
|
2574
PUT
Ares Capital
ARCC
$14.5B
| $2.75M | ﹤0.01% |
+125,000
| New | +$2.66M |
|
2575
Amkor Technology
AMKR
$14.3B
| $2.74M | ﹤0.01% |
130,679
-318,668
| -71% | -$5.88M |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.